Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
784.00    -6.00 (-0.76%)
Bid:
780.00
Ask:
796.00
Spread: 16.00 (2.051%)
Market Cap: £361.39m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

Pre-close trading update

1 Dec 2014 07:00

RNS Number : 3904Y
Porvair PLC
01 December 2014
 



For immediate release 1 December 2014

 

 

 

Pre-close trading update

 

Porvair ("Porvair" or "the Group"), the specialist filtration and environmental technologies group, makes the following announcement regarding trading for the year ended 30 November 2014 ahead of its close period.

 

Porvair has continued to trade strongly throughout the year. Both divisions are expected to deliver record results, with revenue for the full year up 24% (28% at constant exchange rates) and earnings marginally ahead of current market expectations.

 

Strong operating cash flow has increased net cash at the year end to around £5m, achieved after capital investments of £5m, mostly spent on expanding manufacturing capacity to meet demand.

 

As anticipated in previous announcements, Group revenue in 2014 received a one-off boost of £20m (2013: £6m) from several large contracts, each of which is proceeding as expected. Profits on these contracts are recognised after making appropriate allowance for the outstanding liabilities, potential risks and warranties. Consequently, we expect further profits to be achieved as milestones are successfully passed over the period to 2017.

 

Revenue in the Microfiltration division was 34% (36% at constant exchange rates) ahead of the prior year. Underlying revenue growth, excluding the impact of the large projects mentioned above, was 9% (11% at constant exchange rates). Aerospace revenue continued to grow steadily and Seal Analytical recorded a record result for the year.

 

Revenue in the Metals Filtration division was 5% (11% at constant exchange rates) ahead of the prior year. Market share gains continued to be made, particularly in iron foundry filtration. The new plant in Wuhan, China, is performing as expected and revenue from aluminium filtration in China was strong.

 

The Group has adopted IAS19 Revised, Employee Benefits, in the year ended 30 November 2014. This increases the defined benefit pension scheme costs charged in the accounts and requires a revision of prior years. Earnings per share for the year ended 30 November 2013, the comparative period, are restated at 12.3 pence compared with the previously reported 12.7 pence.

 

Order books for the start of 2015 are healthy and the Group has a promising pipeline of potential projects.

 

Porvair will announce its preliminary results for the year ended 30 November 2014 on Monday 26 January 2015.

 

For further information, please contact:

 

Porvair plc

01553 765 500

Ben Stocks, Chief Executive

Chris Tyler, Group Finance Director

 

Buchanan Communications

 

0207 466 5000

Charles Ryland / Steph Watson

 

Notes to editors

 

Porvair plc

Porvair is a group of specialist filtration and environmental technology businesses. Its products are used in a range of niche filtration markets, and are derived from its expertise in the design and manufacture of filtration systems using ceramic, metal, plastic and carbon media. Its Seal Analytical business is a market leader in the manufacture of laboratory based water analysis equipment.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDVLFLZFFLFBK
Date   Source Headline
11th Nov 20201:17 pmRNSHolding(s) in Company
9th Nov 20207:00 amRNSDirectorate Change
23rd Oct 20204:40 pmRNSSecond Price Monitoring Extn
23rd Oct 20204:35 pmRNSPrice Monitoring Extension
7th Oct 20204:35 pmRNSPrice Monitoring Extension
28th Sep 20204:41 pmRNSSecond Price Monitoring Extn
28th Sep 20204:35 pmRNSPrice Monitoring Extension
22nd Sep 20207:00 amRNSNine months trading update
18th Sep 20203:58 pmRNSChange of auditor
2nd Sep 20202:09 pmRNSHolding(s) in Company
19th Aug 20204:03 pmRNSDirector/PDMR Shareholding
10th Aug 20204:40 pmRNSSecond Price Monitoring Extn
10th Aug 20204:36 pmRNSPrice Monitoring Extension
31st Jul 20207:00 amRNSTotal Voting Rights
3rd Jul 20204:41 pmRNSSecond Price Monitoring Extn
3rd Jul 20204:36 pmRNSPrice Monitoring Extension
29th Jun 20207:00 amRNSHalf Year Results 2020
25th Jun 20204:52 pmRNSDirector/PDMR Shareholding
2nd Jun 20204:36 pmRNSPrice Monitoring Extension
20th May 20204:36 pmRNSPrice Monitoring Extension
19th May 20204:36 pmRNSPrice Monitoring Extension
23rd Apr 20209:27 amRNSPublication of Articles of Association
21st Apr 20201:59 pmRNSAGM resolutions and Board changes
8th Apr 20204:03 pmRNSBlock listing six monthly return
8th Apr 20207:00 amRNSTrading Update and Covid-19 Statement
30th Mar 20204:36 pmRNSPrice Monitoring Extension
30th Mar 202012:08 pmRNSSecond Price Monitoring Extn
30th Mar 202012:02 pmRNSPrice Monitoring Extension
26th Mar 202012:07 pmRNSSecond Price Monitoring Extn
26th Mar 202012:02 pmRNSPrice Monitoring Extension
26th Mar 20207:00 amRNSAnnual General Meeting 2020 – Change of Venue
23rd Mar 20204:43 pmRNSSecond Price Monitoring Extn
23rd Mar 20204:38 pmRNSPrice Monitoring Extension
20th Mar 20204:43 pmRNSSecond Price Monitoring Extn
20th Mar 20204:37 pmRNSPrice Monitoring Extension
19th Mar 20204:43 pmRNSSecond Price Monitoring Extn
19th Mar 20204:39 pmRNSPrice Monitoring Extension
18th Mar 202012:08 pmRNSSecond Price Monitoring Extn
18th Mar 202012:03 pmRNSPrice Monitoring Extension
17th Mar 20204:41 pmRNSSecond Price Monitoring Extn
17th Mar 20204:38 pmRNSPrice Monitoring Extension
13th Mar 20204:42 pmRNSSecond Price Monitoring Extn
13th Mar 20204:36 pmRNSPrice Monitoring Extension
6th Mar 202010:20 amRNSHolding(s) in Company
18th Feb 202012:07 pmRNSSecond Price Monitoring Extn
18th Feb 202012:02 pmRNSPrice Monitoring Extension
18th Feb 20207:00 amRNSDirector/PDMR Shareholding
11th Feb 20203:15 pmRNSPDMR Shareholding Grant of Options
3rd Feb 20207:00 amRNSPreliminary Results and Board Changes
18th Dec 20195:39 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.